This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Skin of other and unspecified parts of face
CD2_BENIGN_SKIN_FACE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D23.3&
Hospital discharge: ICD-9
2163
Hospital discharge: ICD-8
21604
Hospital discharge: excluded ICD-9
2163A
Cause of death: ICD-10
D23.3&
Cause of death: ICD-9
2163
Cause of death: ICD-8
21604
Cause of death: excluded ICD-9
2163A
2 out of 7 registries used, show all original rules.
3574
Check minimum number of events None
3574
Include endpoints None
3574
Remove individuals based on genotype QC
3472
CD2_BENIGN_SKIN_FACE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D23
Name in latin
Neoplasma benignum cutis faciei
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Skin of other and unspecified parts of face
based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Skin of other and unspecified parts of face (controls excluding all cancers)
- Other benign neoplasms of skin (controls excluding all cancers)
- Other benign neoplasms of skin
- Benign neoplasms
- Benign neoplasms (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3472 | 1994 | 1478 |
| Unadjusted prevalence (%) | 0.84 | 0.87 | 0.81 |
| Mean age at first event (years) | 57.50 | 54.20 | 61.94 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_SKIN_FACE – Benign neoplasm: Skin of other and unspecified parts of face
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Skin of other and unspecified parts of face
↥Endpoint not on priority list, no data to show.